About Nektar Therapeutics (India) Private Limited
Data last updated: 10 December 2025
Nektar Therapeutics (India) Private Limited is a foreign private limited company based in Tirumalagiri, Telangana, India, a subsidiary of Nektar Therapeutics, Usa. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 16 May 2005, the company has been in operation for over 21 years.
Registered with ROC Hyderabad under CIN U24239AP2005FTC046253.
Capital: an authorised share capital of ₹30 Cr and a paid-up capital of ₹29.39 Cr. It is led by directors including Mark Andrew Wilson and Uday Chandra Yemmanuru.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Tirumalagiri, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.39 Cr, a decline of 8% compared to the previous year.
The company has a workforce of approximately 3 employees as per the latest available data. It operates as a subsidiary of Nektar Therapeutics, Usa.
The company is associated with 1 brand - Nektar.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nektar.com.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social Media
-
Registered AddressPlot No. 105/1 P&T Colony, Tirumalgherry, Tirumalagiri, Telangana, India – 500015
-
IndustryPharma, Pharma Contract R&D
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Nektar Therapeutics (India) Private Limited
Nektar Therapeutics (India) Private Limited has one previous CIN (Corporate Identification Number): U24239AP2005FTC046253. The current CIN is U24239TG2005FTC046253, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2005FTC046253 | Current |
| U24239AP2005FTC046253 | Previous |
Associated Brands with Nektar Therapeutics (India) Private Limited
Nektar Therapeutics (India) Private Limited operates one associated brand: Nektar. These brands represent Nektar Therapeutics (India) Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Therapeutics for multiple diseases are developed using PEGylation platforms. | nektar.com |
Competitors & Alternatives of Nektar Therapeutics (India) Private Limited
Brands and companies operating in the same space as Nektar Therapeutics (India) Private Limited include Jazz Pharmaceuticals, C4 Therapeutics, Erasca and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Jazz Pharmaceuticals
|
Novel biopharmaceutical medicines are developed for unmet medical needs. | Dublin, Ireland, Ireland | 2003 |
C4 Therapeutics
|
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | Cambridge, United States, United States | 2016 |
Erasca
|
Small molecule therapeutics for cancer treatment are developed. | San Diego, United States, United States | 2018 |
Nimbus Therapeutics
|
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed. | Cambridge, United States, United States | 2009 |
Mereo BioPharma
|
Therapeutics for cancer and rare diseases are developed. | London, United Kingdom, United Kingdom | 2015 |
MiRagen
|
MicroRNA-based therapeutics are developed for treating multiple diseases. | Boulder, United States, United States | 2007 |
GSK
|
Developer of pharmaceuticals and vaccines for various therapeutic areas | Brentford, United Kingdom, United Kingdom | - |
Board of Directors of Nektar Therapeutics (India) Private Limited
Nektar Therapeutics (India) Private Limited is currently managed by 3 directors, with 20 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mark Andrew Wilson | Director | 19 Mar 2019 | 7 Years 4 Months | Current |
|
Uday Chandra Yemmanuru
Also directs:
Neoen Global Ventures Llp, Afrem Strategic Ventures Llp, Kvk Par Power Private Limited and 4 more
|
Director | 25 Mar 2024 | 2 Years 3 Months | Current |
| Robert Michael Bacci | Director | 18 Jun 2024 | 2 Years 1 Months | Current |
Financials of Nektar Therapeutics (India) Private Limited FY 2024 filings available
Nektar Therapeutics (India) Private Limited reported revenue of ₹3.39 Cr (down 8.00% YoY) for FY 2025.
Ten-year financial statements for Nektar Therapeutics (India) Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings Nektar Therapeutics (India) Private Limited
Nektar Therapeutics (India) Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Nektar Therapeutics (India) Private Limited
View historical data on people associated with Nektar Therapeutics (India) Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Nektar Therapeutics (India) Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Nektar Therapeutics (India) Private Limited
GST registrations and filing compliance for Nektar Therapeutics (India) Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Nektar Therapeutics (India) Private Limited
Credit ratings, litigation, and regulatory alerts for Nektar Therapeutics (India) Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nektar Therapeutics (India) Private Limited
MSME payment history for Nektar Therapeutics (India) Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nektar Therapeutics (India) Private Limited
Corporate group structure for Nektar Therapeutics (India) Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nektar Therapeutics (India) Private Limited
MCA filings and documents for Nektar Therapeutics (India) Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Nektar Therapeutics (India) Private Limited
Frequently Asked Questions about Nektar Therapeutics (India) Private Limited
Nektar Therapeutics (India) Private Limited is an active foreign private limited company in the pharma sector based in Tirumalagiri, Telangana, India. It was incorporated on 16 May 2005 (21+ years old) and is registered under CIN U24239TG2005FTC046253. The company has 3 employees.
Nektar Therapeutics (India) Private Limited reported revenue of ₹3.39 Cr for FY 2025 (down 8.00% YoY).
The current directors of Nektar Therapeutics (India) Private Limited are:
- Mark Andrew Wilson - Director
- Uday Chandra Yemmanuru - Director
- Robert Michael Bacci - Director
The primary industry of Nektar Therapeutics (India) Private Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.
Nektar Therapeutics (India) Private Limited can be reached at the registered office: Plot No. 1051 P&T Colony, Tirumalgherry, Tirumalagiri, Telangana, India – 500015, or through the website nektar.com.
The authorised capital is ₹30 Cr, and the paid-up capital is ₹29.39 Cr.